Chemours (CC) Director Alister Cowan Receives Award of 7,182 Shares

What Happened

• Alister Cowan, a director of Chemours Co. (CC), was granted 7,182 stock units on 2026-05-06. The Form 4 reports an acquisition (award) of 7,182 units at $0.00 (no cash paid at grant). These units are reported as stock units that will convert one-for-one to common shares upon separation from Board service.

Key Details

• Transaction date: 2026-05-06; Filing date: 2026-05-08 (appears to be within the typical 2-business-day Form 4 window).
• Price reported: $0.00 per unit (award/grant); total cash value at grant shown as $0.
• Shares owned following the transaction: not specified in the provided filing excerpt.
• Footnotes: F1 — units convert one-for-one to Chemours common stock upon separation from Board service. F2 — includes deferred stock units and dividend equivalent units.
• No 10b5-1 plan, tax-withholding sale, or late-filing indicator noted in the supplied data.

Context

• This was a compensation/award grant (not an open-market purchase or sale). Such grants typically reflect director compensation or deferred pay and do not necessarily indicate a near-term bullish or bearish signal. The units are deferred and tied to service/vesting rules and will convert to shares later as described in the footnotes.